Cumulatively, a total of 371 patients were assessed with IHC and, in meta-analysis, metastasis-free survival was 93.8% and 40.6% in pfetin-positive and -negative GIST, respectively. Here, KCTD12 is linked to gastrointestinal stromal tumor.